ALK and anaplastic large cell lymphoma: In ALK+ ALCL cell lines, resistance to both first-generation crizotinib and second-generation alectinib was a result of the emergence of additional mutations beyond the gatekeeper mutation [103] and some mutations, such as I1171, are particularly cross-resistant [94,104].